VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly- Owned ABcann Medicinals. February 11, at am. Published by NCV. 11 hours ago VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly- Owned ABcann Medicinals adult-use products and services, today announces that the Company's subsidiary, ABcann Medicinals Inc. ("ABcann"). 6 hours ago VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly- Owned ABcann Medicinals. February 11, |. No Comments.
Wholly-Owned Announces License to ABcann Cannabis Medicinals VIVO Granted Sales Cannabis Oil
About CannTrust Since its inception in , CannTrust has led the Canadian market in producing a standardized product. As a federally regulated licensed producer, CannTrust brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust currently operates the recently completed , sq. Phase One redevelopment of its , sq. Niagara Perpetual Harvest Facility.
Phase Two redevelopment is expected to be operational in the third quarter and the projected , sq. CannTrust is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive global pharma partner, Apotex Inc. We support ongoing patient education about medical cannabis and have a compassionate use program to support patients with financial needs.
For more information, please visit: The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances, including those relating to: Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with: Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, CannTrust does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
New factors emerge from time to time, and it is not possible for CannTrust to predict all such factors. The risk factors and other factors noted in the AIF could cause actual events or results to differ materially from those described in any forward-looking information.
Sybil Eastman at Strategic Objectives, Tel: T shorters in the deepest water. Short sellers are waiting for an eventual pullback in what they believe is a bubble. Turn on any mainstream media outlet to hear comparisons to crypto and dotcom bubbles. The dedicated shorters are banking on the probable idea that this type of sector wide growth is not sustainable over a long period of time.
The danger the shorters face is that some of these companies will hold their value long term. Shorters may begin to tire over time if the sector continues to heat up as the average cost to borrow stocks in the cannabis sector is a Here are the largest short positions on the TSX, three of the top eleven are cannabis companies. The biggest risk when it comes to shorting is the potential for loss is infinite. While shorting does seem like a profitable way to make money, betting against the wrong company could be devastating.
Take Canopy for example, If Canopy uses its 5 billion dollars from Constellation and builds the largest weed empire in the world that stretches across several continents and generates revenue that not only threatens other cannabis companies, but other industries as well namely pharma, alcohol and tobacco those shorters may be in for one hell of a ride. Copyright , High Energy Trading. The cannabis streaming and royalty business models are attractive for a few different reasons.
Right of first refusal for future expansion. For Phase 1 and Phase 2 build out…total sqft. The first three locations include: This location gives Wildflower products exposure to all the Facebook employees in New York as Facebook currently occupies almost half of the building.
For further information, please contact: This trial should help answer many of these critical questions. We are grateful to Dr. And we commend Tilray for the development of this study drug which has the potential to help thousands of people who struggle with ET. The TSX does not accept responsibility for the adequacy or accuracy of this release. In the last month infamous short outlet Citron has stated they are shorting: Q Namaste Technologies N.
V The biggest risk when it comes to shorting is the potential for loss is infinite. Stay up to date with the latest news. Until — kg over 4 yrs. Nestle Building — kg based on , sqft build out. In July, Pure Sunfarms received its sales license from Health Canada, permitting it to sell cannabis produced in the Delta 3 greenhouse facility.
Pure Sunfarms expects to have the full 1. The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms nine of which are now licensed optimized for year-round harvesting more than 85 harvests annually and an automated process line encompassing harvesting, trimming, drying and packaging.
Village Farms International, Inc. With more than years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient.
Village Farms produces and distributes fresh, premium-quality produce with consistency days a year to national grocers in the U. TBD is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements.
Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom. Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements.
When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities.
The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
With twice as many citizens as the U. There are also ten other countries that have legalized medical marijuana and several others that could pass recreational laws over the next few years. APH acquired Nuuvera Inc.
In addition to providing access to the lucrative Swiss market, the acquisition provided a 64, sq. The company plans to invest CHF4. In addition to its Swiss holdings, the company is one of five in the world to have GMP certification that enables it access to the lucrative German medical market, as opposed to waiting for the tender process. The company has already applied for a license and expects to receive approval during the third quarter to begin cultivation at a , sq.
This means that Maricann can sell cannabis products directly to the German government rather than to consumers or physicians. In late-August, the company also announced that its European nutraceutical subsidiary, MariPlant, commenced the harvest of about hectares of hemp in Germany.
The company managed to collect nearly 3, kilograms of dried material from just four hectares so far, using innovative new equipment developed in Germany. Management believes that it will be able to dry up to 50, kilograms of wet hemp flower per day using these technologies.
And finally, the company also announced a non-binding term sheet to form a strategic joint venture with San Martino, a large scale agricultural giant in Piedmont, Italy. The two companies will develop a centre of excellence for cannabis products in conjunction with the University of Eastern Piedmont. The initial focus will be on high-CBD products for the medical market, but ultimately, THC products for the European market when legal. With these revenue coming from only two large bulk supply orders, shareholders and investors could see further upside, especially as the company has made the decision to consciously preserve inventory ahead of recreational legalization later this year.
The Company made the conscious decision to preserve inventory to meet demand for these strategic long-term sales channels. The company was recently selected by The Ontario Cannabis Store to supply recreational product through its online store launching on October 17, These combined catalysts could help accelerate its future financial results.
With its growing footprint and upcoming recreational legalization, investors may want to take a closer look at the stock given that the market is currently assigning almost no value to its growing European operations.
As it speaks for itself, see the below summary and find the link to the full report below. Through these tolling agreements, the company will process raw cannabis into cannabis resin and finished oils.
Management is developing relationships with a number of existing LPs whereby they will process raw cannabis into cannabis resin and finished oils. The company is also looking to develop white label products where it will provide clients with a finished oil or derivative product. The raw material inputs will either be sourced internally or through the wholesale market. The company is currently capable of processing 6, kg of raw cannabis per month. Furthermore, with the new development of controlled-dose capsules made from extracted oil, it is believed that demand for concentrates and derivative products will overtake flower sales by Additionally, the Canadian government has promised the inclusion of cannabis derivatives in Health Canada legislation by end If the Canadian market follows some of the trends seen in the U.
The first initiative for Valens Farms is to complete a , square foot Phase 1 controlled-environment strain-segregated hybrid greenhouse as part of a large-scale indoor facility on the acre property through its joint venture with Kosha Projects Inc.
As per the agreement, Kosha will contribute the land and all facility development and construction costs. Valens is responsible for all design and outfitting inputs, budgetary guidance, consulting and advisory services during construction and development of the facility. Valens Farms will operate the facility, producing premium quality cannabis and supercritical CO2-extracted cannabis oils.
Phase 1 will be completed in a number of stages: Under the terms of the agreement, the company will purchase cannabis materials from Eticann for use in its proprietary extraction system. This strong cash position will also allow management to pursue strategic acquisitions and address potential working capital requirements.
Mackie Capital Research Report Sept Relevium is focused on the development, acquisition, marketing and sale of consumer products that are derived from cannabis and industrial hemp and other ingredients that are generally accepted as safe. The Company uses cannabinoids and ingredients that have achieved GRAS status generally accepted as safe to create brands that are sold via wholesale channels, retail channels and online distribution. Relevium markets its products as dietary supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals.
The Company plans on unveiling a complete line of dietary supplements for consumers derived from Cannabis Sativa and Cannabis Indica. Relevium is also focused on developing a complete line of supplements, nutraceuticals, sports nutrition and nutri-cosmeceuticals.
Cautionary Note Regarding Forward-Looking Statements This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws.
All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will be able to apply for and ultimately obtain an ACMPR licence, the proposed business of Biocannabix will develop as anticipated, that the Company will raise sufficient funds to develop the Biocannabix business, and that the Company will obtain all requisite regulatory approvals.
Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed business developments may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.
We seek safe harbor. The BlissCo team has been focused on scaling up its operations in preparation for commercialization by securing its oil production license , developing an e-commerce strategy , building its network of partners and other high-impact initiatives. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships. BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.
These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.
The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law. The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
The company anticipates its Frankfurt listing imminently. He has held senior positions with Equinet AG, Bankhaus Sal Oppenheim largest European private bank at that time as head of global proprietary trading and managing partner at Proprietary Partners AG, a Swiss based hedge fund advisory company.
Importantly DGWA consults to various companies, investors, institutions and federal organizations regarding their investment strategy. There is significant interest within Europe for regulated medical cannabis companies and we believe Pure Global Cannabis is one of the most attractive companies listed today. Pure Global Cannabis will be of particular interest to European retail, institutional and strategic investors as many are seeking greater exposure to global cannabis revolution.
Pure Global Cannabis Inc. PRCNF is a vertically-integrated, growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, consumer packaged goods CPG , and supply chain experts. Follow pureglobalcanna on Twitter and Facebook and pureglobalcannabis on Instagram. Forward-looking statements involve significant risk, uncertainties and assumptions.
Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements.
These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law. A copy of this report may be obtained by contacting Investor Relations, MedMen Enterprises, at investors medmen.
Ashley McGrath, and Mr. Chris Buysen have joined the board of directors of the Company. John Cullen has resigned as a director of the Company and Dr. Management and the board of directors would like to thank Mr. He advises a number of public companies on a variety of matters including continuous disclosure and regulatory matters, reverse takeover transactions, initial public offerings and takeover bids.
Irwin is also a director and officer of several public companies. Kaushal sits on the boards of numerous public and private companies. McGrath has been involved in real estate development for 14 years as the President and Owner of Glencoe Developments Inc.
He has overseen all aspects of the development business including land acquisition, finance and sales of over , square feet of development space. He oversees the management of a large rental portfolio of residential and commercial real estate and is a shareholder in an agribusiness operating over , square feet of indoor livestock production as well as a 23, acre grain farm.
Buysen has held numerous senior financial positions with reporting issuers over the past 15 years including his current role as Chief Financial Officer of the Company. He has also held a leadership role in a multi-family office, advising high net worth families on investment, business and other financial matters. While funded capacity may have been the buzzword over the past couple of years, quality and distribution have become the most important considerations as the market comes online.
Everyone is starting from the same point when it comes to building a brand reputation in the new industry. SpeakEasy Cannabis Club Ltd. The podcast has already received over 51, listens and has global reach.
SpeakEasy Cannabis Club represents a collective of the top growers in Canada, sharing decades of knowledge and experience to produce the finest product in the world.
Listen to the Podcast on The Green Scene. Marc Geen carried on the tradition of Sun-Rype by bringing together a collective of world-class growers with a lifetime of experience producing the best cannabis in the world. SpeakEasy acts as an incubator that shares knowledge, resources, and operational expertise with these independent growers—a model similar to YCombinator in Silicon Valley.
The result is a rich set of ultra-premium products, each with their own unique story behind them. With everyone starting at the same point, the company is working on innovative packaging and branding that will set its products apart on store shelves. The combination of authenticity and product quality will ultimately determine which licensed producers succeed, with premium products commanding 66 percent higher prices in many markets.
While the license has been pending, the company has been busy planning for its second phase of growth. The team began an 80, sq. The goal is for everyone to work together in the same area without having to worry about the added logistics and complexity associated with managing a multi-province footprint.
The post In-Depth Interview: Sutherland has a successful track record within the cannabis sector. His past achievements and contributions include holding the position of founding Chief Operating Officer of Bedrocan Cannabis Corp. The terms of the Units will remain the same as previously announced see news release dated July 10, White Sheep is a commercial operator and strategic investor in global cannabis assets with direct operational expertise in building successful, large-scale, automated cannabis grow facilities and meeting regulatory and compliance standards.
Asterion is a Canadian cannabis company with operations in Australia, specializing in organic medical cannabis with a goal of becoming an industry leader in next generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality, genetically uniform cannabis strains, at an affordable price. The Company is led by a team of highly experienced executives with over years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.
Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the biotechnology or medical cannabis industry and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company.
These forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements.
Although the Company believes that the statements, beliefs, plans, expectations, and intentions contained in this news release are reasonable, there can be no assurance that those statements, beliefs, plans, expectations, or intentions will prove to be accurate.
Readers should consider all of the information set forth herein and should also refer to other periodic reports provided by the Company from time-to-time.
Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Further detail on the offering is below. Flowr, through its subsidiaries, is a vertically-integrated cannabis company and Health Canada Licensed Producer that currently offers premium quality cannabis under the FlowrRx brand in the Canadian medicinal market.
The Company has agreements with several provinces to provide its Flowr brand premium cannabis for sale in province-controlled adult-use retail channels following the expected October 17, legalization of adult recreational use in Canada. Flowr expects the facility to reach full capacity in , targeted to be in excess of 12, kilograms annually. The Company is also building a 50, square foot research and development facility integrated into its Kelowna campus and funded through an exclusive alliance with the Hawthorne Gardening subsidiary of The Scotts Miracle-Gro Company NYSE: The Offering was comprised of both a brokered and a non-brokered financing.
The Subscription Receipts sold as part of the brokered financing were sold pursuant to the terms of an agency agreement dated August 28, among the Company, Needle, Clarus Securities Inc. The Company and Needle are currently working on the documentation to complete the Transaction, which is expected to close on or prior to September 10, Upon completion of the Transaction, it is intended that the net proceeds from the Offering will be used for facility expansion, marketing initiatives, capacity expansion, working capital and general corporate purposes.
All securities of Flowr issued pursuant to the Offering are subject to a hold period ending on the later of: Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon.
Trading in the securities of Flowr should be considered highly speculative. The Needle Capital Corp. The Company was incorporated on June 1, , and is headquartered in Calgary, Alberta. Flowr, through its subsidiaries, is a vertically-integrated Canadian cannabis company focused on the natural science of cannabis.
With a sense of craftsmanship and a spirit of innovation, Flowr is also well positioned with a line of premium quality cannabis products for the upcoming adult-use market. This news release contains certain forward-looking statements that reflect the current views or expectations of management of Flowr and Needle with respect to performance, business and future events, including but not limited to express or implied statements and assumptions regarding completion of the Transaction and the use of proceeds from the Offering.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
Such factors include, among others, the following risks: Such factors include, among others: Flowr cautions that the foregoing list of material factors is not exhaustive. Flowr has assumed that the material factors referred to in the previous paragraph will not cause such forward-looking statements and information to differ materially from actual results or events.
However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. The forward-looking information contained in this press release represents the expectations of Flowr as of the date of this press release and, accordingly, is subject to change after such date.
Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date.
Flowr does not undertake to update this information at any particular time except as required in accordance with applicable laws. The post The Flow Corp. We strongly believe that our planned approach to cannabis oil will reinforce this position, and that our customers will appreciate the quality and value of these products.
JWC intends to offer its newly developed medical cannabis oil products, in varying content and size configurations in anticipation of patient and customer demands. JWC further intends to offer volume discounts on oil products to its customers, while targeting to provide the lowest price per mg currently available in Canada. JWC is eager and excited to provide patients with affordable and accessible medical cannabis oils, in addition to its already widely-available aeroponically-grown dried cannabis products.
JWC was founded as a family company and prides itself on its family values. Since its inception, JWC has remained focused on providing the best possible patient experience. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For more information about this release, please contact:.
The post James E. Based on the recently released California State Cannabis tax revenues, these figures easily place our dispensaries in the top ten percent state wide. We expect to make further announcements imminently. A vertically integrated cannabis company, Captor provides recreational and medical marijuana based products to consumers via its leading brands and dispensary locations.
Listed on the Canadian Securities Exchange, the OTCUSA, and the Frankfurt Stock Exchange, Captor owns and operates advanced growing facilities which produce consistent high quality contaminant free marijuana for its customers, as well as other high demand cannabis based goods for consumption.
The company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis investments including two wholly owned branded MedMen dispensaries — the world famous West Hollywood location and the showpiece Orange County dispensary in Santa Ana.
Captor Capital is currently looking at additional revenue generating investments in the cannabis space and will be updating the market in due course. This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets.
Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results.
Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law. All interested parties are invited to participate. Its genetics are grown to exacting standards, ensuring patients can count on receiving the highest-quality cannabis products.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. Actual future results may differ materially. The business of the Company is subject to a number of material risks and uncertainties.
Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the Company being able to obtain the necessary corporate, regulatory and other third parties approvals, and licensing and other risks associated with regulated ACMPR entities.
The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein. The post 48North Cannabis Corp. Lexaria is food biosciences company that has the technology for improved delivery of bioactive compounds. In particular, the Canadian cannabis stock offers a variety of hemp oil products to its consumers and also has some novel food offerings like a black tea infused with hemp oil.
Lineage is a company focused on holding a lineup of licensed producer assets across the US and Canada. The company plans to deploy craft quality product thanks to cultivation techniques and genetics for this approach.
Koios is a company working on the development of a beverage for cognition-improving results. Thanks to a robust distribution network the company can offer its drink to consumers in the US.
Lotus Ventures is a medical marijuana company seeking a license in Canada for the production of cannabis. The company is seeking to produce high end product with a low cost in its BC facilities. Liberty was formed by Aphria as a multi-state operator set to take advantage of the cannabis opportunity in states with favorable cannabis laws in the US.
The company has developed a network of dispensaries and patients in Florida. Aphria maintains a right to purchase its stake in the company despite selling it in Liberty Leaf Holdings is focused on the business of acquiring partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis investment space.
Marapharm is a company with assets in Washington, Nevada and California in the US and Canada through a late stage license applicant for cannabis production. Maricann is a licensed producer and a distributor of cannabis in Canada. The company has secured supply agreements with provinces in Canada for the start of recreational use in the country. The company has been able to capitalize on the international play for cannabis companies thanks to its EU-GMP certified facility in Ontario.
Matica is to become a majority owner of a cannabis facility in Quebec. The facility is a late stage applicant to a Canadian license for legal production. The company has also raised capital to construct a new growth facility in Hemmingford, Quebec, which one completed is projected to offer 1 million square feet of greenhouse property.
The company also has a partnership with Cronos Group meant to open the door for the option to open MedMen branded shops in Canada. The company completed the acquisition of Canveda, a licensed producer in Canada as its play into the country. MYM Nutraceuticals is a company seeking acquisitions of Health Canada licenses for the production of cannabis. The company holds assets in Quebec, where it seeks to construct a medical cannabis greenhouse complex that can also serve as a tourism space with various entertainment options including a hotel.
NanoSphere is a biotech company with an entry into the cannabis space thanks to its patented delivery system. This technology is made to be a more efficient delivery system for the biological agents of cannabis. The rights to its product were negotiated to Delta 9 Cannabis to bring forward for Health Canada approval.
Nutritional High is a Canadian cannabis stock focused on cannabis-infused edible products and oil extracts for both the medical and recreational market. The company is focussed exclusively in the US cannabis market through its assets in legal states. Next on our stock list for cannabis investment is Phivida. Thanks to nanoencapsulation technology, the company transforms lipid based cannabinoids into a water soluble delivery format, which the company claims enhances bioavailability and timed released within the body.
PreveCeutical is a company with a health sciences approach to the development of preventive and curative therapies with cannabis. The company has established an Australian subsidiary to expand its research and development efforts. PUF Ventures has a diversified portfolio of assets in the Canadian marijuana sector. The company seeks to create value for shareholders through acquisitions, joint ventures and other projects in the market.
The company also offers dispensing devices and consumption products. Ravenquest is a diversified cannabis company with facilities in Alberta and Ontario focused on the production of cannabis, management and consulting services in the industry and specific research of new products. This company offers a novel play into the cannabis space to investors. As a merchant bank Redfund offers debt and equity options to cannabis companies in the space.
Through this alternative capital companies are able to continue developing facilities or general business models in the cannabis space. RISE Life Science is a company developing cannabis consumer products for both medical and adult-use markets.
The company plans to establish a potential capacity in to market all of its CBD products throughout the US, Canadian and European markets. Scythian is a research and development company with a patent application for the use of cannabinoids for the treatment of brain trauma injuries. Scythian sold its Latin American network of interests to Aphria, including an entry into the Colombian market.
Sunniva is a vertically integrated cannabis company operating in California, thanks to a , square feet facility in the state. The company has decided to spin out its Canadian assets in an attempt to create value for existing shareholders, Sunniva Medical which is constructing the Sunniva Canada Campus in BC, into a new publicly traded company.
Sproutly is a company with an LP asset growing cannabis for the company to develop its infused beverage products thanks to the acquisition of Infusion Biosciences. Kris Dahl, VP of corporate development for the company, told INN their technology improved the efficiency of the effects from consuming these infused products.
Tinley Beverage is the producer of Hemplify, a drinkable vitality supplement containing hemp extract made from the stalk of industrial hemp. Canada-based True Leaf is slightly different than the aforementioned Canadian cannabis stocks; the company is focused on the production of hemp-based functional dog chews and other pet products. The network of assets Valen GroWorks holds complete its cannabis business with research and production.
Veritas is using a specifically designed approach to their research where they chemically and pharmacologically profile the plant. Next on our stock list for cannabis investment is Vodis.
The firm has medical and recreational marijuana business operations in both Canada and the United States. These company, as its name indicates, has a targeted approach to brand construction and development. Xanthic is a company working with strategic partners to deliver a higher quality of cannabinoid solubility, improved bioavailability, accurate micro-dosing and greater consistency versus competitive infused products, thanks to a patent-pending process.
Maple Leaf is a company with interests in both the Canadian and US cannabis markets. In the US the company holds a medical cultivation license in Nevada and is seeking a recreational one as well.
Did we miss a company that you think should be included on the Canadian cannabis stocks list? Let us know in the comments! This article has been updated since its original publication in , with the most recent update done by Bryan Mc Govern. I, Jocelyn Aspa and Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article. This article is not paid-for content. Please remember that by requesting an investor kit, you are giving permission for those companies to contact you using whatever contact information you provide.
If you want more than 20 investor kits, you need to make multiple requests. Select 20, complete the request and then select again. By selecting company or companies above, you are giving consent to receive communication from those companies using the contact information you provide. And remember you can unsubscribe at any time. I will add it to the list for the next update. Thanks for the tip! LAG was mentioned alongside Naturally Splendid. Wonderful products and a huge following and retail exposure.
I was looking for just this. Do you have recommendation of cannabis brokers in the Montreal area? You seem to have left off several: I believe these are all on the TSX: They are located in Kelowna and have just completed their final stage inspection pre licensing. A big one out there that is going to do very well is Emblem Corp.
Apologies for the oversight, and thanks for pointing that out! I will be sure to add them to the list. They jump from 0. Since December , this title has seen an explosive growth, from 0. I follow nutritional high. EAT they have had some impressive gains. Ate they not big enough to endorse or are they a poor business model in this industry? Your report is sadly outdated and I would request that it be updated.
This is disappointing but the new timing of legalization is now predicted to be October not Spring — thank Trudeau for dragging this out. Where did you hear it would be postponed until October? Please let us know your source, as I had heard springtime was when legalization would happen. I keep hearing about a huge IPO coming on April 17 or thereabouts, which company is it, does anyone know?
Cannabis Investment: Canadian Cannabis Stocks
10 hours ago BRIEF-VIVO Cannabis Announces Cannabis Oil Sales License Granted To Wholly-Owned Abcann Medicinals. 10 hours ago Amendment to production license allows for sale of cannabis oil Granted to Wholly-Owned ABcann Medicinals at New Cannabis Ventures. 11 hours ago Inc. (VVCIF: OTCQX International) | VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly-Owned ABcann Medicinals.